Retatrutide has emerged as a new pharmaceutical in the fight against obesity. This groundbreaking drug, categorized as a dual GLP-1 and GIP receptor agonist, demonstrates promising results in clinical trials. By https://albiexfrs838731.designertoblog.com/67479430/retatrutide-a-promising-new-treatment-for-obesity